JRDG:LSE:LSE-JPMorgan ETFs (Ireland) ICAV - Global Research Enhanced Index Equity UCITS ETF - USD (dist) GBX (GBX)

ETF | Others |

Last Closing

USD 3790.25

Change

+77.25 (+2.08)%

Market Cap

N/A

Volume

4.18K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+1.13 (+0.41%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+4.98 (+3.58%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.12 (+0.90%)

USD 584.80B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.01 (-0.06%)

USD 583.82B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-1.60 (-2.46%)

USD 266.08B
0QZO:LSE 0QZO

+2.10 (+2.18%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

-0.04 (-0.12%)

USD 204.07B
0QZ3:LSE Qualcomm Inc.

+6.38 (+3.87%)

USD 202.26B

ETFs Containing JRDG:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.84% 76% C+ 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.84% 76% C+ 73% C
Trailing 12 Months  
Capital Gain 24.31% 72% C 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.31% 72% C 69% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.11% 61% D- 66% D+
Dividend Return 9.11% 61% D- 65% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.77% 68% D+ 81% B-
Risk Adjusted Return 93.24% 90% A- 94% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike